IL-33、IL-37、NLRP3及NK/DC比值与慢性乙型肝炎患者病情相关性研究

doi:10.3969/j.issn.1000-8535.2023.10.007

摘要/Abstract

摘要： 目的探讨与研究白介素-33（IL-33）、白介素-37（IL-37）、亮氨酸富集的核苷酸结合寡聚结构域-3（NLRP-3）及自然杀伤（NK）细胞/树突状细胞（DC）比值与慢性乙型肝炎（CHB）患者病情的相关性。方法研究时间为2020年2月—2022年9月,选择在本院诊治的86例CHB患者作为肝炎组,同期选择86名体格检查健康者作为对照组。检测2组血清IL-37、IL-33、NLRP3含量,并计算NK/DC比值。对所有入选者的血清谷丙转氨酶（ALT）、谷草转氨酶（AST）、总胆红素（TBIL）含量进行检测并实施相关性分析。结果与对照组相比,肝炎组的血清ALT、TBIL、AST有的增高趋势（P<0.05）,肝炎组的血清IL-33、IL-37、NLRP3含量更高（P<0.05）,NK/DC比值下降（P<0.05）。在肝炎组中,Pearson分析显示IL-33、IL-37、NLRP3、NK/DC比值与ALT、TBIL、AST均存在相关性（P<0.05）。在肝炎组中,ROC曲线分析显示IL-33、IL-37、NLRP3、NK/DC比值预测CHB病情的曲线下面积为0.705（95%CI：0.404~1.123）、0.690（95%CI：0.372~1.057）、0.670（95%CI：0.378~1.043）、0.685（95%CI：0.415~1.107）,联合检测预测病情的曲线下面积为0.895（95%CI：0.532~1.216）,与单独检测相比,联合检测具有更高的特异度与灵敏度。结论 CHB患者多伴随有血清IL-33、IL-37、NLRP3的高表达,并且NK/DC比值会降低,IL-33、IL-37、NLRP3及NK/DC比值与CHB患者病情存在相关性,联合检测对患者病情具有一定的预测性。

关键词: 白介素-33, 白介素-37, 亮氨酸富集的核苷酸结合寡聚结构域-3, 自然杀伤细胞/树突状细胞比值, 慢性乙型肝炎

Abstract: Objective To explore and study the correlation between interleukin-33(IL-33),interleukin-37(IL-37),leucine-enriched nucleotide-binding oligomeric domain(NLRP)- 3,the ratio of natural killer(NK)cells/dendritic cells(DC)and the conditions of patients with chronic hepatitis B(CHB). Methods From February 2020 to September 2022,86 patients with CHB treated in our hospital were selected as hepatitis group,and 86 healthy patients were selected as control group during the same period. The contents of IL-37,IL-33 and NLRP3 in serum of the two groups were detected,and NK/DC ratio was calculated. Serum alanine aminotransferase(ALT),aspartate aminotransferase(AST)and total bilirubin(TBIL)of all the selected subjects were detected and correlation analysis was carried out. Results Compared with the control group,the serum ALT,TBIL and AST in hepatitis group were significantly increased(P<0. 05),the contents of IL-33,IL-37 and NLRP3 were higher(P<0. 05),and the NK/DC ratio was significantly decreased(P<0. 05). In the hepatitis group,Pearson analysis showed that IL-33,IL-37,NLRP3 and NK/DC ratios were correlated with ALT,TBIL and AST(P<0. 05). In the hepatitis group,ROC curve analysis showed that the maximum areas under the curve of IL-33,IL-37,NLRP3 and NK/DC ratios were 0. 705(95%CI：0. 404-1. 123),0. 690(95%CI：0. 372-1. 057),0. 670(95%CI：0. 378-1. 043)and 0. 685(95%CI：0. 415-1. 107),and the maximum area under the curve of combined detection was 0. 895(95%CI：0. 532-1. 216). Compared with single detection,combined detection had higher specificity and sensitivity. Conclusions The patients with CHB are often accompanied by the high expression of serum IL-33,IL-37 and NLRP3,and the NK/DC ratio will be significantly reduced. IL-33,IL-37,NLRP3 and NK/DC ratio are correlated with the condition of patients with CHB,and can also predict the condition of patients.

Key words: interleukin-33, interleukin-37, leucine-enriched nucleotide-binding oligodomain-3, natural killer cell/dendritic cell ratio, chronic hepatitis B

于雅丽. IL-33、IL-37、NLRP3及NK/DC比值与慢性乙型肝炎患者病情相关性研究[J]. 广州医药, 2023, 54(10): 52-57.

YU Yali. Study on the correlation between IL-33,IL-37,NLRP3,NK/DC ratio and the condition of patients with chronic hepatitis B[J]. Guangzhou Medical Journal, 2023, 54(10): 52-57.

参考文献

[1] 熊翠欢. 桂西北地区某高校5届新生HBV感染状况分析[J].保健医学研究与实践,2008,5(2):6-7.
[2] 李解军,冯煦,常瑞霞.HBsAg、cccDNA和pgRNA水平检测在慢性乙型肝炎诊治中的价值[J].保健医学研究与实践,2021,18(4):95-98,102.
[3] DU X X,SHI Y,YANG Y,et al.DAMP molecular IL-33 augments monocytic inflammatory storm in hepatitis B-precipitated acute-on-chronic liver failure[J].Liver Int,2018,38(2):229-238.
[4] GAO X,CHI X,WANG X,et al.IL-33 inhibits hepatitis B virus through its receptor ST2 in hydrodynamic HBV mouse model[J].Mediators Inflamm,2020(2020):1403163.
[5] KHAN H A,MUNIR T,KHAN J A,et al.IL-33 ameliorates liver injury and inflammation in Poly I:C and Concanavalin-A induced acute hepatitis[J].Microb Pathog,2021(150):104716.
[6] 杨晓飞,申焕君,黄高铂,等.HBV感染者外周血自然杀伤样B淋巴细胞、自然杀伤细胞、B淋巴细胞亚群的变化及临床意义[J].临床肝胆病杂志,2022,38(7):1489-1494.
[7] ABE K,TAKAHASHI A,FUJITA M,et al.Interleukin-33/ST2-mediated inflammation plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis[J].Hepatol Commun,2019,3(5):670-684.
[8] ARTRU F,BOU SALEH M,MAGGIOTTO F,et al.IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis[J].J Hepatol,2020,72(6):1052-1061.
[9] 吴凤萍,鲁瑞,刘怡欣,等.基于GEO数据库筛选慢性乙型病毒性肝炎患者对干扰素α治疗无应答相关的关键免疫基因和通路[J].西安交通大学学报(医学版),2022,43(3):407-412.
[10] ASKOURA M,ABBAS H A,AL SADOUN H,et al.Elevated levels of IL-33,IL-17 and IL-25 indicate the progression from chronicity to hepatocellular carcinoma in hepatitis C virus patients[J].Pathogens,2022,11(1):57.
[11] 李劲,骆仲榆,陈刘镇,等.慢性乙型肝炎病毒感染患者血清IL-33、sST2、MCP-1水平变化及其临床意义[J].中国医药导报,2019,16(17):125-128.
[12] 刘琼,杨歆,唐简,等.慢性乙型肝炎患者外周血单个核细胞Tim-3和血清IL-33表达及临床意义[J].中华医院感染学杂志,2020,30(13):2014-2017.
[13] 吴苏君,冀恒涛,彭梦乐.IL-18、IL-37、NLRP3及NK/DC比值在乙型肝炎相关肝硬化中的临床价值[J].检验医学,2022,37(6):518-523.
[14] 丁光伟,段淑芬,高春耕,等.更昔洛韦联合还原型谷胱甘肽对巨细胞病毒性肝炎患者肝功能及Th1/Th2平衡的影响[J].中西医结合肝病杂志,2021,31(5):424-427.
[15] 刘斌,张莉,任红,等.慢性乙型肝炎病毒感染患者外周血自然杀伤细胞和树突状细胞比例与肝损伤的关系[J].上海交通大学学报(医学版),2017,37(8):1094-1099.
[16] 高海丽,杨道坤,王宏伟,等.血清IL-33水平与慢性乙型肝炎肝纤维化病情严重程度的相关性研究[J].齐齐哈尔医学院学报,2022,43(6):528-531.
[17] 钟权涛,冉枭,张烨琼,等.乙型肝炎患者血清中IL-37水平变化[J].热带医学杂志,2017,17(4):442-446.
[18] 李凡,罗薇,白纪红,等.慢性乙型肝炎肝硬化患者NLRP3及下游因子表达水平和意义[J].广东医学,2019,40(6):782-786.